c.difficilecolonization and ribotypes in hong kong 787
residents with prior C. difficile infection. Infect Control Hosp Epidemiol 2012;33:638–639.
7. Kim JH, Toy D, Muder R. Clostridium difficile infection in a long- term care facility: hospital-associated illness compared with long- term care-associated illness. Infect Control Hosp Epidemiol 2011;32:656–660.
8. Mylotte JM, Russell S, Sackett B, Vallone M, Antalek M. Surveillance for Clostridium difficile infection in nursing homes. J Am Geriatr Soc 2013;61:122–125.
9. Ponnado S, Guerrero DM, Jury LA, et al. Acquisition of Clos- tridium difficile colonization and infection after transfer from a Veterans Affairs hospital to an affiliated long-term care facility. Infect Control Hosp Epidemiol 2017;38:1070–1076.
10. Luk S,ToWK, NgTK, et
al.Acost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar. J ClinMicrobiol 2014;52:671–673.
11. Bidet P, Lalande V, Salauze B, et al. Comparison of PCR ribotyping, arbitrarily primed PCR, and pulsed-field gel elec- trophoresis for typing Clostridium difficile. JClinMicrobiol 2000;38:2484–2487.
12. Joost I, Speck K, Herrmann M, von Müller L. Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing. Int J Antimicrob Agents 2009;33(Suppl 1):S13–S18.
13. Mahoney FI, Barthel D. Functional evaluation: the Barthel index. Md State Med J 1965;14:61–65.
14. Ziakas PD, Zacharioudakis IM, Zervou FN,Grigoras C, Pliakos EE, Mylonakis E. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS One 2015;10:e0117195.
15. Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper EJ. High prevalence of Clostridium difficile colonization
among nursing home residents in Hesse, Germany. PLoS One.7: e30183.
16. Walker KJ, Gilliland SS, Vance-Bryan K, et al. Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc 1993;41:940–946.
17. Ryan J, Murphy C, Twomey C, et al. Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics. Ir JMed Sci 2010;179:245–250.
18. Luk S, Ho YM, Ng TK, et al. Prevalence, prediction and clonality of methicillin-resistant Staphylococcus aureus (MRSA) carriage at admission to medical units in Hong Kong, China. Infect Control Hosp Epidemiol 2014;35:42–48.
19. Na’amnih W, Adler Amos, Miller-Roll T, Cohen D, Carmeli Y. Incidence and risk factors for community and hospital acquisi- tion of Clostridium difficile infection in the Tel Aviv Sourasky Medical Center. Infect Control Hosp Epidemiol 2017;38:912–920.
20. Luk S,WongWK, Ho AYM, Yu KCH, To WK, Ng TK. Clinical features and molecular epidemiology of plasmid-mediated DHA-type AmpC β-lactamase–producing Klebsiella pneumo- niae blood culture isolates, Hong Kong. J Glob Antimicrob Resist 2016;7:37–42.
21. Rodriguez C, Taminiau B, Korsak N, et al. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol 2016;16:229.
22. Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis 1993;17:672–678.
23. Johnson S, Homann SR, Bettin KM, et al. Treatment of asympto- matic Clostridium difficile carriers (fecal excretors) with vancomy- cin ormetronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992;117:297–302.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144
